The Existing Premises. Landlord and Tenant hereby agree that pursuant to the Lease, Landlord currently leases to Tenant and Tenant currently leases from Landlord a total of 82,835 rentable square feet consisting of (i) 67,694 rentable square feet in the 26642 Building, (ii) 6,515 rentable square feet in Suite 100 of the 26672 Building, (iii) 5,317 rentable square feet in Suite 150 of the 26672 Building, and (iv) 3,309 rentable square feet in Suite 310 of the 26672 Building (collectively, the “Existing Premises”), as outlined on Exhibit “A” to the Lease.
Appears in 2 contracts
The Existing Premises. Landlord and Tenant hereby agree that pursuant to the Lease, Landlord currently leases to Tenant and Tenant currently leases from Landlord a total of 82,835 22,229 rentable and 19,818 usable square feet (consisting of (i) 67,694 9,628 rentable and 8,584 usable square feet in of space on the 26642 Building, first (ii1st) 6,515 floor of the Building and 12,601 rentable and 11,234 usable square feet in Suite 100 of space on the second (2nd) floor of the 26672 Building, (iii) 5,317 rentable square feet in Suite 150 of the 26672 Building, and (iv) 3,309 rentable square feet in Suite 310 of the 26672 Building commonly known as Suites 100 and 200 (collectively, the “Existing Premises”), as outlined on Exhibit “A” to more particularly described in the Lease.
Appears in 1 contract
Samples: Lease (Orexigen Therapeutics, Inc.)
The Existing Premises. Landlord and Tenant hereby agree that pursuant to the Lease, Landlord currently leases to Tenant and Tenant currently leases from Landlord a total of 82,835 approximately 22,229 rentable and 19,818 usable square feet (consisting of (i) 67,694 9,628 rentable and 8,584 usable square feet in of space on the 26642 Building, first (ii1st) 6,515 floor of the Building and 12,601 rentable and 11,234 usable square feet in Suite 100 of space on the second (2nd) floor of the 26672 Building, (iii) 5,317 rentable square feet in Suite 150 of the 26672 Building, and (iv) 3,309 rentable square feet in Suite 310 of the 26672 Building (collectively, the “Existing Premises”), as outlined on Exhibit “A” to more particularly described in the Lease.
Appears in 1 contract
Samples: Lease (Orexigen Therapeutics, Inc.)
The Existing Premises. Landlord and Tenant hereby agree that pursuant to the Lease, Landlord currently leases to Tenant and Tenant currently leases from Landlord a total of 82,835 approximately 18,477 rentable (16,003 usable) square feet in the Building consisting of (i) 67,694 approximately 13,487 rentable (11,681 usable) square feet in on the 26642 Buildingfourth (4th) floor of the Building and commonly known as Suite 400, and (ii) 6,515 approximately 4,990 rentable (4,322 usable) square feet in Suite 100 on the third (3rd) floor of the 26672 Building, (iii) 5,317 rentable square feet in Building and commonly known as Suite 150 of the 26672 Building, and (iv) 3,309 rentable square feet in Suite 310 of the 26672 Building 300 (collectively, the “Existing Premises”), all as outlined on Exhibit “A” to more particularly described in the LeaseFourth Amendment.
Appears in 1 contract
Samples: Lease (Auspex Pharmaceuticals, Inc.)